空气污染代谢组特征与慢性呼吸系统疾病风险:一项纵向研究。

IF 9.5 1区 医学 Q1 CRITICAL CARE MEDICINE Chest Pub Date : 2024-11-01 Epub Date: 2024-07-25 DOI:10.1016/j.chest.2024.06.3809
Bingting Zhuo, Shanshan Ran, Aaron M Qian, Junguo Zhang, Maya Tabet, Steven W Howard, Zilong Zhang, Fei Tian, Hualiang Lin
{"title":"空气污染代谢组特征与慢性呼吸系统疾病风险:一项纵向研究。","authors":"Bingting Zhuo, Shanshan Ran, Aaron M Qian, Junguo Zhang, Maya Tabet, Steven W Howard, Zilong Zhang, Fei Tian, Hualiang Lin","doi":"10.1016/j.chest.2024.06.3809","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although evidence has documented the associations of ambient air pollution with chronic respiratory diseases (CRDs) and lung function, the underlying metabolic mechanisms remain largely unclear.</p><p><strong>Research question: </strong>How does the metabolomic signature for air pollution relate to CRD risk, respiratory symptoms, and lung function?</p><p><strong>Study design and methods: </strong>We retrieved 171,132 participants free of COPD and asthma at baseline from the UK Biobank, who had data on air pollution and metabolomics. Exposures to air pollutants (particulate matter with diameter ≤ 2.5 μm [PM<sub>2.5</sub>], particulate matter with a diameter ≤ 10 μm, nitrogen oxide [NO<sub>X</sub>], and NO<sub>2</sub>) were assessed for 4 years before baseline considering residential address histories. We used 10-fold cross-validation elastic net regression to identify air pollution-associated metabolites. Multivariable Cox models were used to assess the associations between metabolomic signatures and CRD risk. Mediation and pathway analysis were conducted to explore the metabolic mechanism underlying the associations.</p><p><strong>Results: </strong>During a median follow-up of 12.51 years, 8,951 and 5,980 incident COPD and asthma cases were recorded. In multivariable Cox regressions, air pollution was positively associated with CRD risk (eg, hazard ratio per interquartile range increment in PM<sub>2.5</sub>, 1.09; 95% CI, 1.06-1.13). We identified 103, 86, 85, and 90 metabolites in response to PM<sub>2.5</sub>, particulate matter with a diameter ≤ 10 μm, NO<sub>X</sub>, and NO<sub>2</sub> exposure, respectively. The metabolomic signatures showed significant associations with CRD risk (hazard ratio per SD increment in PM<sub>2.5</sub> metabolomic signature, 1.11; 95% CI, 1.09-1.14). Mediation analysis showed that peripheral inflammatory and erythrocyte-related markers mediated the effects of metabolomic signatures on CRD risk. We identified 14 and 12 perturbed metabolic pathways (energy metabolism and amino acid metabolism pathways, etc) for PM<sub>2.5</sub> and NO<sub>X</sub> metabolomic signatures.</p><p><strong>Interpretation: </strong>Our study identifies metabolomic signatures for air pollution exposure. The metabolomic signatures showed significant associations with CRD risk, and inflammatory- and erythrocyte-related markers partly mediated the metabolomic signatures-CRD links.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"975-986"},"PeriodicalIF":9.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.\",\"authors\":\"Bingting Zhuo, Shanshan Ran, Aaron M Qian, Junguo Zhang, Maya Tabet, Steven W Howard, Zilong Zhang, Fei Tian, Hualiang Lin\",\"doi\":\"10.1016/j.chest.2024.06.3809\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although evidence has documented the associations of ambient air pollution with chronic respiratory diseases (CRDs) and lung function, the underlying metabolic mechanisms remain largely unclear.</p><p><strong>Research question: </strong>How does the metabolomic signature for air pollution relate to CRD risk, respiratory symptoms, and lung function?</p><p><strong>Study design and methods: </strong>We retrieved 171,132 participants free of COPD and asthma at baseline from the UK Biobank, who had data on air pollution and metabolomics. Exposures to air pollutants (particulate matter with diameter ≤ 2.5 μm [PM<sub>2.5</sub>], particulate matter with a diameter ≤ 10 μm, nitrogen oxide [NO<sub>X</sub>], and NO<sub>2</sub>) were assessed for 4 years before baseline considering residential address histories. We used 10-fold cross-validation elastic net regression to identify air pollution-associated metabolites. Multivariable Cox models were used to assess the associations between metabolomic signatures and CRD risk. Mediation and pathway analysis were conducted to explore the metabolic mechanism underlying the associations.</p><p><strong>Results: </strong>During a median follow-up of 12.51 years, 8,951 and 5,980 incident COPD and asthma cases were recorded. In multivariable Cox regressions, air pollution was positively associated with CRD risk (eg, hazard ratio per interquartile range increment in PM<sub>2.5</sub>, 1.09; 95% CI, 1.06-1.13). We identified 103, 86, 85, and 90 metabolites in response to PM<sub>2.5</sub>, particulate matter with a diameter ≤ 10 μm, NO<sub>X</sub>, and NO<sub>2</sub> exposure, respectively. The metabolomic signatures showed significant associations with CRD risk (hazard ratio per SD increment in PM<sub>2.5</sub> metabolomic signature, 1.11; 95% CI, 1.09-1.14). Mediation analysis showed that peripheral inflammatory and erythrocyte-related markers mediated the effects of metabolomic signatures on CRD risk. We identified 14 and 12 perturbed metabolic pathways (energy metabolism and amino acid metabolism pathways, etc) for PM<sub>2.5</sub> and NO<sub>X</sub> metabolomic signatures.</p><p><strong>Interpretation: </strong>Our study identifies metabolomic signatures for air pollution exposure. The metabolomic signatures showed significant associations with CRD risk, and inflammatory- and erythrocyte-related markers partly mediated the metabolomic signatures-CRD links.</p>\",\"PeriodicalId\":9782,\"journal\":{\"name\":\"Chest\",\"volume\":\" \",\"pages\":\"975-986\"},\"PeriodicalIF\":9.5000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chest\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.chest.2024.06.3809\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2024.06.3809","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

背景:尽管有证据表明环境空气污染与慢性呼吸系统疾病(CRD)和肺功能有关,但其潜在的代谢机制在很大程度上仍不清楚:研究问题:空气污染的代谢组特征与 CRD 风险、呼吸系统症状和肺功能有何关系?我们从英国生物库中检索了 171,132 名基线时没有慢性阻塞性肺病(COPD)和哮喘的参与者,他们都有空气污染和代谢组学数据。考虑到居住地址历史,我们对基线前 4 年暴露于空气污染物(直径≤2.5 μm 的颗粒物 [PM2.5]、PM10、氮氧化物 [NOX] 和二氧化氮)的情况进行了评估。我们使用 10 倍交叉验证弹性净回归来确定与空气污染相关的代谢物。采用多变量 Cox 模型评估代谢组特征与 CRD 风险之间的关联。研究人员还进行了中介分析和路径分析,以探索这些关联背后的代谢机制:在中位 12.51 年的随访期间,分别记录了 8951 例和 5980 例慢性阻塞性肺病和哮喘病例。在多变量 Cox 回归中,空气污染与 CRD 风险呈正相关(例如,PM2.5 每四分位间增量的危险比 [HR]:1.09;95% 置信区间 [CI]:1.06-1.13):1.06-1.13).针对 PM2.5、PM10、NOX 和 NO2 暴露,我们分别确定了 103、86、85 和 90 种代谢物。代谢组特征显示与 CRD 风险有显著关联(PM2.5-代谢组特征每标准差(SD)增量的 HR:1.11;95% ci:1.13):1.11;95% CI:1.09-1.14)。中介分析表明,外周炎症和红细胞相关标记介导了代谢组特征对 CRD 风险的影响。我们为PM2.5和NOX-代谢组特征分别确定了14条和12条受干扰的代谢途径(能量代谢和氨基酸代谢途径等):我们的研究确定了空气污染暴露的代谢组特征。代谢组特征与慢性阻塞性肺疾病风险有显著关联,炎症和红细胞相关标记物部分介导了代谢组特征与慢性阻塞性肺疾病的联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.

Background: Although evidence has documented the associations of ambient air pollution with chronic respiratory diseases (CRDs) and lung function, the underlying metabolic mechanisms remain largely unclear.

Research question: How does the metabolomic signature for air pollution relate to CRD risk, respiratory symptoms, and lung function?

Study design and methods: We retrieved 171,132 participants free of COPD and asthma at baseline from the UK Biobank, who had data on air pollution and metabolomics. Exposures to air pollutants (particulate matter with diameter ≤ 2.5 μm [PM2.5], particulate matter with a diameter ≤ 10 μm, nitrogen oxide [NOX], and NO2) were assessed for 4 years before baseline considering residential address histories. We used 10-fold cross-validation elastic net regression to identify air pollution-associated metabolites. Multivariable Cox models were used to assess the associations between metabolomic signatures and CRD risk. Mediation and pathway analysis were conducted to explore the metabolic mechanism underlying the associations.

Results: During a median follow-up of 12.51 years, 8,951 and 5,980 incident COPD and asthma cases were recorded. In multivariable Cox regressions, air pollution was positively associated with CRD risk (eg, hazard ratio per interquartile range increment in PM2.5, 1.09; 95% CI, 1.06-1.13). We identified 103, 86, 85, and 90 metabolites in response to PM2.5, particulate matter with a diameter ≤ 10 μm, NOX, and NO2 exposure, respectively. The metabolomic signatures showed significant associations with CRD risk (hazard ratio per SD increment in PM2.5 metabolomic signature, 1.11; 95% CI, 1.09-1.14). Mediation analysis showed that peripheral inflammatory and erythrocyte-related markers mediated the effects of metabolomic signatures on CRD risk. We identified 14 and 12 perturbed metabolic pathways (energy metabolism and amino acid metabolism pathways, etc) for PM2.5 and NOX metabolomic signatures.

Interpretation: Our study identifies metabolomic signatures for air pollution exposure. The metabolomic signatures showed significant associations with CRD risk, and inflammatory- and erythrocyte-related markers partly mediated the metabolomic signatures-CRD links.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chest
Chest 医学-呼吸系统
CiteScore
13.70
自引率
3.10%
发文量
3369
审稿时长
15 days
期刊介绍: At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.
期刊最新文献
Chronic obstructive pulmonary disease-associated expiratory central airway collapse: current concepts and new perspectives. Evolution of DLCO in LAM: Historical Perspectives and the Role of Advanced Imaging. Plasma Protein Biomarkers of Spirometry Measures of Impaired Lung Function. Keeping up with technological innovation: the moral imperative for pragmatic clinical trials in interventional pulmonology. Dietary pattern, sputum DNA methylation, and lung health: an epidemiological study in people who ever smoked.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1